MFDS
- Status: likely_approved
🇰🇷 Vraylar in South Korea
Vraylar (CARIPRAZINE) regulatory status in South Korea.
Marketing authorisation
Vraylar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Vraylar approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Vraylar in South Korea?
AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.